Company intelligence / Profile preview

SHATTER Fund

Danville, California, United States

Ownership: Private
Development stage: Other

Overview

SHATTER Fund is an early-stage venture capital firm focused on consumer technology and digital health companies. The firm backs founders building technologies intended to expand access to healthcare, capital, and opportunity, with a stated emphasis on category-defining platforms and inclusive entrepreneurship. SHATTER Fund is led by founder and managing partner Shelly Kapoor Collins, and the current SHATTER Fund II leadership also includes Dr. Rhodo Nguyen. Although it is healthcare-related through its investment focus, it is not a drug-development biotech or pharma operating company and does not appear to run an in-house therapeutic pipeline.

Industry: Investors

Beyond the preview

Go deeper on SHATTER Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHATTER Fund.

Explore the full profile